BetterLife Pharma announced a legal claim filed by independent director Steven Sangha in British Columbia's Supreme Court regarding repayment of a convertible debenture issued in June 2026. Sangha seeks conversion of the debenture into over 33 million common shares and an equal number of share warrants. The company intends to vigorously defend against the claim. This dispute could impact BetterLife's financial position as it develops neurological disorder treatments, including its key drug candidate BETR-001.
BetterLife Pharma's legal dispute over a convertible debenture is notable alongside today's health sector market activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 10, 2026 01:11 WIB: out of 128 priced US health-sector stocks, 110 rose and 16 fell. Notable movers include Humana Inc (HUM) at USD 435.00 with a 12.37% increase and a typical hold time of 51 days, Moderna, Inc. (MRNA) at USD 220.32 up 11.84% with a 59-day hold time, and Heron Therapeutics Inc (HRTX) at USD 0.40 rising 10.75% with a 35-day hold time. Pluang order activity shows strong buying interest in HUM with 93% buy orders.
MindWave Innovations Inc., a subsidiary of Apimeds Pharmaceuticals US, signed three agreements within 10 days to create dedicated blockchain networks for clients in climate finance, sports media, and insurance. Each network runs on MindWave's MindCha...
Park Aerospace reported Q2 fiscal 2027 earnings that exceeded expectations, with EPS of $0.21 versus $0.16 estimated and revenue of $20.8 million beating the $20 million forecast. The company showed strong profitability with a 34.3% gross margin and ...
On October 9, 2026, WF Holding's stock soared nearly 500% on extremely high volume despite no confirmed catalyst. Veea rose 47.3% after regaining full Nasdaq listing compliance by resolving governance issues. Fastly gained 15.9% following an Oppenhei...
First Commonwealth Financial Corporation announced it will hold a conference call and webcast on October 28, 2026, at 2:00 p.m. ET to discuss its third quarter 2026 financial results. The earnings press release will be published after market close on...
Brookfield Corporation announced it will release its third quarter 2026 financial results on November 12, 2026, at 7:00 a.m. ET, followed by a conference call and webcast at 10:00 a.m. ET. Investors and analysts can join the call via pre-registration...
